[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Gaucher Disease Market Opportunities Analysed in GlobalData Report Available at MarketPublishers.com

02 Mar 2016 • by Natalie Aster

LONDON – As of 2014, sales for the Gaucher Disease marketplace almost hit the USD 875 million mark across 7 major markets (7MM), namely the USA, Germany, France, Israel, Spain, the UK and Italy. The USA was a leader in terms of sales: it generated more than USD 480 million.

Sales are expected to continue increasing in the years to come, with its CAGR being just under 3 percent. They are forecast to be around USD 1.2 billion in 2024, and the USA will maintain its position of the number one player. As of 2024, this country will account for more than 56 percent f the GD marketplace in the 7MM.

The number of diagnosed prevalent cases of the disease is expected to register growth in the years to come, and, consequently, the treated GD population will also grow.

Growing GD awareness coupled with increasing physician population is set to lead to improved diagnosis in the near term.  However, large percentage of the GP population will stay undiagnosed.

At present, the GD pipeline is sparsely populated and there are no drugs being in the late-stage of development, and this poses a challenge to the market growth.

Cutting-edge research report “Gaucher Disease - Opportunity Analysis and Forecast to 2024” prepared by GlobaData offers an up-close look at the GD marketplace. The study provides a thorough overview of the disease covering etiology and pathophysiology, its symptoms, prognosis and a quality of life. It investigates the epidemiology, looks at global trends and contains epidemiological forecasts for GD. The report sheds light on current treatment options, assesses unmet needs and analyzes existing opportunities. The research study contains data on R&D strategies and a pipeline assessment. It comprises a competitive assessment and a top-line 10-year forecast.

Report Details:

OpportunityAnalyzer: Gaucher Disease - Opportunity Analysis and Forecast to 2024
Published: December, 2015
Pages: 244
Price: US$ 9,495.00

More insightful research reports by this publisher are available at GlobalData page


The Market Publishers, Ltd.
Natalie Aster
Tel: +44 208 144 6009
Fax: +44 207 900 3970
[email protected] 

Analytics & News

Weekly Digest